Appendix II Top 100 Longevity Investor Profiles 1. ABN AMRO 34. Flagship Pioneering 67. Partners Innovation Fund 2. Accuitive Medical Ventures 35. Forbion Capital Partners 68. Piper Jaffray Private Capital Group 3. Advantech Capital 36. Formation 8 69. Polaris Partners 4. Alexandria Venture 37. GE Capital 70. RA Capital Management 5. Ally Bridge Group 38. GE Ventures 71. Ramius Advisors 6. ALS Finding a cure 39. General Catalyst 72. Sanofi-Genzyme BioVentures 7. AME Cloud Ventures 40. GV 73. Shibuya Kogyo 8. Amino Capital 41. Harvest Global Investments 74. Silicon Valley Bank 9. Ann Arbor SPARK 42. Horizon Ventures 75. Sino-Alliance International LTD 10. ARCH Venture Partners 43. Illumina 76. S.R.I.W 11. Arkin Holdings 44. Integrale Advisors 77. Sphera Funds Management 12. Aspire Capital Partners LLC 45. Inventages Capital Investment inc 78. Springboard Capital 13. ATEL Ventures 46. Jennison Associates 79. StartUp Health 14. BRCC 47. Juno Therapeutics 80. Sutter Hill Ventures 15. Brainchild Holdings 48. Juvenescence Limited 81. SWMF Life Science Fund 16. Cardinal Partners 49. Khosla Ventures 82. Syno Capital 17. Casdin Capital 50. LabCorp 83. Synthetic Genomics 18. Celgene 51. Legend Capital 84. T. Rowe Price 19. CIRM 52. LYZZ Capital 85. Tan Thay 20. Cyberdyne 53. Magic Stone Alternative 86. Techammer 21. Deep Knowledge Life Sciences 54. Mayo Clinic Ventures 87. Techno Venture Management 22. Deerfield Partners 55. Merck Ventures 88. Testudo Funds 23. DeNovo Ventures 56. NanoDimension 89. The Thiel Foundation 24. DFJ 57. Nazem and Company 90. Third Rock Ventures 25. Easton Capital 58. New Science Ventures 91. Toray Engineering 26. EcoR1 Capital 59. Nivelinvest 92. TVM Capital 27. Eight Roads Ventures 60. Odey Asset Management 93. TYLT Ventures 28. Emerson Collective 61. Odey Swan 94. Venrock 29. Essex Woodlands Health Ventures 62. Omega Funds 95. Versant Ventures 30. F-Prime Capital Partners 63. OrbiMed 96. Vertex Ventures 31. Ferghana Partners 64. OS Fund 97. Viking Global Investors 32. Fidelity Investments 65. Oxford Finance Corporation 98. Vives Fund 33. First Analysis 66. Oxford Sciences Innovation 99. Warburg Pincus 100. WuXi Healthcare Ventures 542 ABN AMRO Summary: ABN AMRO is a Dutch banking company based in Amsterdam. Although they offer financial services, they also offer advice in finance and networking regions. Number of Investments: 40 Headquarters: Amsterdam, Netherlands Year Founded: 1991 Total Investments (USD): $6.95B Stages: Early Stage Venture, Late Stage Venture, Seed Sectors: Fintech Typical Investment: 100k-1M Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: $15M Series A in April 2015 with 13 other investors (Aaron Levie, AME Cloud Ventures, Drew Houston, Formation 8, Julia Hartz, Katie Stanton, Khosla ventures, Laurene Powell Jobs, Mariam Naficy, Max Levchin, Padmasree Warrior, Raymond Tonsing, Ruchi Sanghvi) 543 Accuitive Medical Ventures Summary: AMV invest in healthcare-related business ventures, specifically targeting device and technology companies at all stages of development. Number of Investments: 45 Headquarters: Duluth, Georgia, USA Year Founded: 2003 Total Investments (USD): N/A Stages: Seed, Early Stage, Late Stage, Debt Financing Sectors: Healthcare, Biotechnology, Medical Devices Typical Investment: $4M - $6M Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: AxoGen - 12.1M Post-IPO Equity in December 2007 with 3 other investors (Springboard Capital, Cardinal Partners and Denovo Ventures) 544 Advantech Capital Advantech Capital Summary: A Chinese investment firm, Advantech Capital specialises in growth investment and works closely with healthcare companies in China. Number of Investments: 4 Headquarters: China Year Founded: 2015 Total Investments (USD): $215M Stages: Early Stage, Late Stage Sectors: Technology, Healthcare, Media and Communications Typical Investment: $15M-$100M Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Harbour BioMed - $50M (Series A) in Dec, 2016 with 1 other investor (Advantech Capital, Legend Capital) 545 Alexandria Venture Summary: Alexandria, a private investment company in San Francisco, provides equity for commercial and residential properties. Their Venture branch forms REIT for Science and Tech companies. Number of Investments: 28 Headquarters: San Francisco, California Year Founded: 1996 Total Investments (USD): $1.3B Stages: Early Stage Sectors: Biotechnology Typical Investment: N/A Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Editas Medicine - $120M (Series B) in Aug, 2015 with 14 other investors (Boris Nikolic, Casdin Capital, Deerfield, EcoR1 Capital, Fidelity Management and Research Company, Flagship pioneering, GV, Jennison associates, Khosla Ventures, Omega funds, Polaris partners, T. Rowe Price, Third Rock Ventures, Viking Global Investors) 546 Ally Bridge Group Summary: Ally Bridge is an investment firm specialising in the healthcare technology sector. Number of Investments: 12 Headquarters: Hong Kong, HK Island Year Founded: 2013 Total Investments (USD): $264.07M Stages: Early Stage, Late Stage, Private Equity, Secondary Market, Post IPO Sectors: Biopharmaceuticals, Medical devices Typical Investment: N/A Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Hua Medicine - $25M Series B with 1 other investor (Venrock) in January 2015 547 ALS Finding a cure Summary: ALS Finding a cure is a company dedicated to finding solutions and providing support for those suffering from ALS. Consequently, extended funding is placed into research organisations offering support for related diseases and afflictions. Number of Investments: 2 Headquarters: Stamford, Connecticut Year Founded: 2013 Total Investments (USD): $19.96M Stages: Early Stage, Late Stage, Private Equity Sectors: Healthcare Typical Investment: N/A Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Emulate Inc. - $17M (Series B) in October 2016 with 2 other investors (ATEL Ventures, Cedars Sinai Medical Center) 548 AME Cloud Ventures Summary: Founded by the original co-founder of 'Yahoo!', AME Cloud Ventures specialises in tech companies that generate vast amounts of interesting data from a multitude of sources. Number of Investments: 152 Headquarters: Palo Alto, California Year Founded: 2012 Total Investments (USD): N/A Stages: Seed, Early Stage, Late Stage Sectors: Cloud Computing, Enterprise Software, Enterprises Typical Investment: N/A Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Emulate Inc. - $17M (Series B) in October 2016 with 6 other investors (ATEL Ventures, Cedars Sinai Medical Center, Hansjorg Wyss, NanoDimension, OS Fund, Techammer) 549 Amino Capital Summary: Amino Capital (zPark Capital), based in Palo Alto, is interested in seed to growth-stage investments followed by series A and B investments in data-driven technologies. Number of Investments: 56 Headquarters: Palo Alto, California Year Founded: 2012 Total Investments (USD): $50M Stages: Seed, Early Stage Sectors: Big Data, Health IT, Genomics, Enterprise Software, Consumer Hardware Typical Investment: 200k-10M Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Human Longevity Inc.: $220M Series B with 5 other investors (Illumina, Celgene, Draper Fisher Jurvetson, GE Ventures, StartUp Health) in April 2016 550 Ann Arbor SPARK Summary: A non-profit organisation offering programs and pro-active support to businesses. Ann Arbor SPARK works with businesses from different sectors, including engineering, life sciences, and information technologies Number of Investments: 89 Headquarters: Ann Arbor, Michigan Year Founded: 2005 Total Investments (USD): N/A Stages: Seed, Early Stage, Debt Financing Sectors: Healthcare, IT, Social Media, Materials, Alt Energy Typical Investment: $0.05M - $2M Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Axonia Medical - $2M Seed in May 2012 with 1 other investor (SWMF Life Sciences Fund) 551 ARCH Venture Partners Summary: Recognised for its success in the commercialisation of technologies developed at research institutes and laboratories, ARCH works with companies to promote innovations in life sciences, physical sciences, and IT. Number of Investments: 238 Headquarters: Chicago, Illinois Year Founded: 1986 Total Investments (USD): $1.2B Stages: Early Stage, Late Stage, Private Equity Sectors: Biotechnology, Healthcare, Clean Technology Typical Investment: $50K - $150M Investments in Geroscience, Regenerative Medicine and P3 Medicine Companies: Bluebird Bio - $60M (Series D) in Jul, 2012 from 6 other Investors (RA Capital Management, Deerfield Partners, Third Rock Ventures, Forbion Capital Partners, TVM Capital, Ramius Advisors); Bluebird Bio - $30M (Venture) in Apr, 2011 from 4 other Investors (Third Rock Ventures, TVM Capital, Forbion Capital Partners, Easton Capital, ARCH Venture Partners) ; Hua Medicine - $50M Series A with 5 other investors (Eight Roads Ventures, F-Prime Capital Partners, Sino-alliance International Ltd., Venrock, WuXi Healthcare Ventures) in September 2011 ; Semma Therapeutics - $44M Series A with 3 other investors (F-Prime Capital Partners, Medtronic, MPM Capital) 552 Arkin Holdings Summary: Arkin Holdings is an Israeli Venture Capital company that does Early Stage Investments. The company focuses on aspiring healthcare R&D enterprises. Number of Investments: 4 Headquarters: Tel Aviv, Israel Year Founded: 2010 Total Investments